CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
This Quarter Return
+10.93%
1 Year Return
+64.74%
3 Year Return
+147.29%
5 Year Return
–
10 Year Return
–
AUM
$15B
AUM Growth
+$15B
(+4.3%)
Cap. Flow
-$648M
Cap. Flow
% of AUM
-4.33%
Top 10 Holdings %
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34
Top Buys
| 1 |
Installed Building Products
IBP
|
$68.5M |
| 2 |
Corpay
CPAY
|
$57.4M |
| 3 |
Baker Hughes
BKR
|
$50.9M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$48.8M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$46.2M |
Top Sells
| 1 |
Insulet
PODD
|
$86.4M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$56.2M |
| 3 |
WEC Energy
WEC
|
$50.1M |
| 4 |
A.O. Smith
AOS
|
$48.9M |
| 5 |
C.H. Robinson
CHRW
|
$41.8M |
Sector Composition
| 1 | Technology | 21.48% |
| 2 | Healthcare | 17.37% |
| 3 | Industrials | 15.16% |
| 4 | Consumer Discretionary | 13.51% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
PNC Financial Services
PNC
$80.9B
| $26.6M | 0.18% |
166,367
-3,252
| -2% | -$519K |
|
202
Americold
COLD
$4.01B
| $26.5M | 0.18% |
756,250
-529,750
| -41% | -$18.6M |
|
203
Guardant Health
GH
$8.29B
| $26.2M | 0.18% |
335,487
+180,180
| +116% | +$14.1M |
|
204
Generac Holdings
GNRC
$10.5B
| $26.1M | 0.17% |
259,100
-95,450
| -27% | -$9.6M |
|
205
FTI Consulting
FCN
$5.46B
| $25.8M | 0.17% |
233,550
-29,925
| -11% | -$3.31M |
|
|
MRTX
206
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $25.7M | 0.17% |
+199,814
| New | +$25.7M |
|
207
Brown & Brown
BRO
$31.5B
| $25.7M | 0.17% |
649,975
-676,250
| -51% | -$26.7M |
|
208
Atmos Energy
ATO
$26.6B
| $25.6M | 0.17% |
229,099
-188,550
| -45% | -$21.1M |
|
209
McDonald's
MCD
$225B
| $25.5M | 0.17% |
128,935
-2,521
| -2% | -$498K |
|
210
Evolent Health
EVH
$1.11B
| $25.3M | 0.17% |
2,801,065
| – | – |
|
211
Arch Capital
ACGL
$34.1B
| $25.2M | 0.17% |
588,000
-17,750
| -3% | -$761K |
|
212
Host Hotels & Resorts
HST
$11.7B
| $25.2M | 0.17% |
1,356,509
-44,125
| -3% | -$819K |
|
213
Medtronic
MDT
$120B
| $25M | 0.17% |
220,640
-4,314
| -2% | -$489K |
|
214
Insmed
INSM
$30.7B
| $25M | 0.17% |
1,046,301
| – | – |
|
215
Automatic Data Processing
ADP
$121B
| $25M | 0.17% |
146,394
-2,862
| -2% | -$488K |
|
216
Lam Research
LRCX
$123B
| $24.9M | 0.17% |
+85,075
| New | +$24.9M |
|
217
Union Pacific
UNP
$132B
| $24.8M | 0.17% |
137,125
-42,438
| -24% | -$7.67M |
|
|
DRNA
218
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $24.7M | 0.16% |
1,120,359
| – | – |
|
|
EVBG
219
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $24.6M | 0.16% |
314,669
+10,000
| +3% | +$781K |
|
|
GBT
220
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $24.4M | 0.16% |
307,452
| – | – |
|
221
Comcast
CMCSA
$126B
| $24.4M | 0.16% |
543,202
-20,120
| -4% | -$905K |
|
222
Crown Castle
CCI
$42.7B
| $24.4M | 0.16% |
171,322
-3,350
| -2% | -$476K |
|
223
TotalEnergies
TTE
$137B
| $23.8M | 0.16% |
430,466
-8,415
| -2% | -$465K |
|
224
Euronet Worldwide
EEFT
$3.74B
| $23.6M | 0.16% |
149,900
+132,400
| +757% | +$20.9M |
|
225
BioMarin Pharmaceuticals
BMRN
$11.3B
| $23.3M | 0.16% |
276,075
+196,650
| +248% | +$16.6M |
|